A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

NCT03710252 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin

Sponsor

American Research Corporation

Collaborators

[object Object]